Gene · 445
NIH grants1,983
NIH grants whose papers are about the gene, through NIH's grant-paper links.
61 to 80 of 1,983
Download this page as JSON| Grant | Title | ASS1 papers | Newest fiscal year |
|---|---|---|---|
| R01DK062277 | Role of Wnt-Beta-catenin in liver development and metabolic zonation | 2 | 2025 |
| R01DK078081 | Metabolic crosstalks in regulation of beta-cell stress response and adaptation | 2 | 2025 |
| R01DK103775 | Role and regulation of beta-catenin in cholestatic liver disease | 2 | 2025 |
| R01DK105550 | Exploiting metabolic vulnerabilities of CD4 T cell subsets to control inflammatory disease | 2 | 2025 |
| R01GM134681 | The role of DNA damage tolerance pathways in human cells | 2 | 2025 |
| R01NS124728 | Understanding the mechanisms that modulate the effects of mutant Huntingtin lowering in aging Huntington's disease model mice | 2 | 2025 |
| R35AG071476 | Alzheimer's Clinical Trial InnOvatioN (ACTION) Initiative | 2 | 2025 |
| R35CA220449 | Human metabolic variation as a window into cancer initiation and progression | 2 | 2025 |
| R35CA220483 | Metabolic Influences on Complex Tumor Neighborhoods | 2 | 2025 |
| R35CA242379 | Understanding the role of metabolism in cancer | 2 | 2025 |
| R35CA242457 | Making cancer precision medicine real: bottlenecks and opportunities | 2 | 2025 |
| R35CA274446 | Biology and genetics of metastatic disease | 2 | 2025 |
| R35GM122595 | Mechanisms of Iron-Sulfur Dependent Reactions | 2 | 2025 |
| R37CA237421 | Intratumoral Metabolic Crosstalk Promotes Therapeutic Resistance in Pancreatic Cancer | 2 | 2025 |
| RM1HG009490 | Center for Genomic Editing and Recording: Development and Application of Next-Generation Genome and Epigenome Editing Methods to Advance the Study and Treatment of Human Disease | 2 | 2025 |
| T32AG000096 | Training in the Neurobiology of Aging and Alzheimers Disease | 2 | 2025 |
| T32CA221709 | Cancer Metabolism Training Program | 2 | 2025 |
| T32DK094775 | Training in Basic and Translational Digestive Sciences | 2 | 2025 |
| T32HL007013 | Training in Comparative Lung Biology and Medicine | 2 | 2025 |
| U19AG032438 | Bridge Funding for Dominantly Inherited Alzheimer Network | 2 | 2025 |
Source NIH's project filesgene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/445/grants?page=4